These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group. Mycophenolate Mofetil Acute Renal Rejection Study Group Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408 [TBL] [Abstract][Full Text] [Related]
12. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Pelletier RP; Akin B; Henry ML; Bumgardner GL; Elkhammas EA; Rajab A; Ferguson RM Clin Transplant; 2003 Jun; 17(3):200-5. PubMed ID: 12780668 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Kreis H; Cisterne JM; Land W; Wramner L; Squifflet JP; Abramowicz D; Campistol JM; Morales JM; Grinyo JM; Mourad G; Berthoux FC; Brattström C; Lebranchu Y; Vialtel P Transplantation; 2000 Apr; 69(7):1252-60. PubMed ID: 10798738 [TBL] [Abstract][Full Text] [Related]
15. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression. Tsai MK; Hu RH; Lee CJ; Lee PH J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188 [TBL] [Abstract][Full Text] [Related]
17. Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil. Le Meur Y; Thierry A; Glowacki F; Rerolle JP; Garrigue V; Ouali N; Heng AE; Delahousse M; Albano L; Lang P; Couzi L; Jaureguy M; Lebranchu Y; Mousson C; Glotz D; Kessler M; Vrtovsnik F; Rouanet S; Tagieva N; Kamar N Transplantation; 2011 Dec; 92(11):1244-51. PubMed ID: 22067312 [TBL] [Abstract][Full Text] [Related]
18. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients. Kovac D; Kotnik V; Kandus A Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086 [TBL] [Abstract][Full Text] [Related]
19. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416 [TBL] [Abstract][Full Text] [Related]
20. Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppression. Tojimbara T; Nakajima I; Sato S; Nakamura M; Kawase T; Kai K; Tsuda S; Kudo S; Fuchinoue S; Teraoka S Transplant Proc; 2004 Sep; 36(7):2087-9. PubMed ID: 15518755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]